Does TOCILIZUMAB Cause Poor venous access? 287 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 287 reports of Poor venous access have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.3% of all adverse event reports for TOCILIZUMAB.
287
Reports of Poor venous access with TOCILIZUMAB
0.3%
of all TOCILIZUMAB reports
19
Deaths
144
Hospitalizations
How Dangerous Is Poor venous access From TOCILIZUMAB?
Of the 287 reports, 19 (6.6%) resulted in death, 144 (50.2%) required hospitalization, and 9 (3.1%) were considered life-threatening.
Is Poor venous access Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 287 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Poor venous access?
VEDOLIZUMAB (1,043)
INFLIXIMAB (917)
INFLIXIMAB-DYYB (782)
ECULIZUMAB (555)
HUMAN IMMUNOGLOBULIN G (504)
NATALIZUMAB (422)
RITUXIMAB (299)
METHOTREXATE (257)
ABATACEPT (249)
IDURSULFASE (175)
Which TOCILIZUMAB Alternatives Have Lower Poor venous access Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE